Second cycle, 250mcg split AM/PM. Week 3 I started getting small firm lumps at injection sites. Nothing red or hot, just pea-sized bumps. First cycle I didn’t get these. Tracked the difference. Main thing: tighter injection rotation. This time I’m cycling quads, glutes, shoulders, knees close together instead of spacing them out week-to-week. What I changed: switched from 1.5ml BAC water to 2ml (dilutes it more), massaged injection sites hard for 60 seconds post-shot, and forced a wider site rotation - not returning to the same spot for 2 weeks minimum. Lumps softened within 5 days. Gone by day 10. BPC works in the tissue. If you’re jabbing the same small area every other day, inflammation builds. More volume, wider spacing, post-injection work. Not an excuse to stop. Just means adjust. Back to training. Knee’s still responding.
edit: forgot to add
“tighter injection rotation” is the right diagnosis, and I’ve seen this play out the same way. ran my first BPC cycle subq abdomen-only bc the plantar fascia protocols I was working from called for localized targeting, got identical firm lumps around week 2. widened rotation to laterals and anterior thigh with a minimum 12-14 days before returning to the same spot, and they cleared on basically the same timeline as yours. the dilution volume point is worth making more explicit: going from 1.5ml to 2ml BAC water on a 250mcg dose drops local peptide concentration at the deposit site by roughly 25%. the massage helps disperse what’s already pooled, but adjusting the volume changes what you’re depositing in the first place.
those are doing different things, and the dilution is probably doing more of the heavy lifting. one thing worth tracking separately: “cycling quads, glutes, shoulders, knees” spans both IM and subq territory depending on technique. lump mechanics differ between the two, and if any of those shots are landing IM instead of subq, the tissue response isn’t identical. not saying that’s the issue here, just that it muddies the data if you’re trying to isolate the variable
60-second post-injection massage is probably doing more work than the dilution change tbh. the BAC volume shift is fine but subq pea-sized nodules are almost always local histamine response plus peptide depot forming in undertreated tissue, and mechanical disruption breaks that up fast. ran into the same thing cycle two, shorter abdomen-only rotation, and adding 30 seconds of actual pressure (not just rubbing) cleared it in about a week. the 2-week site rest rule tracks with what I’ve seen.
didn’t separate IM from subq in my tracking, just logged site names and dates, so you’re right - dilution concentration and injection mechanics both floating in the data. concentration probably doing most of teh heavy lifting.
ymmv.
The “concentration probably doing most of the heavy lifting” framing is worth pushing on, because the mechanism is likely tonicity, not just absolute peptide amount. More dilute solutions are closer to tissue osmolality, which reduces local inflammatory response independent of injection mechanics entirely. The reason higher BAC volume helps isn’t only that it disperses the compound over more tissue surface area - it’s that the solution is less irritating to the surrounding cells from the moment of injection. That’s a different explanation than “more dilution = less peptide per milliliter = less reaction.” The IM vs subq separation matters more than you might be giving it credit for. Those two routes produce structurally different lump types and different resolution timelines, so without that variable isolated, attributing the outcome primarily to dilution is still a stretch. The data supports that something worked, not which thing. On the tracking side, one small fix for the friction problem: I started using the CareClinic app’s watch complication to timestamp injection sites in the moment rather than reconstructing from memory later. That gap between action and logging is usually where the useful granularity disappears.
Spacing and massage are the actual fixes - dilution alone probably wouldn’t make that difference.
did you switch BAC water suppliers when you upped from 1.5 to 2ml? bacteriostatic concentration isn’t standardized - ranges from 0.9% to higher - and cheaper sources irritate subq tissue more, especially with repeat injections where local flow’s limited. the extra volume helped, sure, but if you also unknowingly switched to cleaner water, that’s probably the real fix. next cycle, test this: keep the rotation tight but go back to your original BAC source. lumps return, you’ve isolated the variable.
dunno.
1.5 to 2ml is probably your actual fix here, diluting 250mcg into more volume just reduces tissue concentration and irritation. spacing and massage help but you changed three things at once, so you can’t tell which one actually solved it.
The 2ml dilution is worth flagging for people on lower volumes - some compounders send 5ml vials reconstituted to 1ml, and subq delivery into concentrated solution absolutely concentrates the local tissue response. The “2 weeks minimum before returning to same spot” is exactly right; most people treat rotation like a suggestion rather than a structural rule.
That pea-sized lump thing sucks, especially skipping your first cycle. BPC sits in tissue, so hammering the same spot daily builds irritation - you’re tracking that right.
But you changed three things at once (volume, massage, rotation), so you don’t know which fixed it. I’d reckon the 1.5ml to 2ml jump is doing most of the work - diluting 250mcg into more volume just lowers tissue concentration and eases irritation upfront. The rotation and massage help, but the dilution tackles inflammation directly. Next cycle, change one thing. That’s how you know what works
rotating away from the injury site might trade one problem for another. there’s animal literature suggesting proximal delivery outperforms distal injection for tendon/ligament repair - peptide concentration at the target tissue is higher when you’re not migrating to your quad for a shoulder issue. i keep my rotator cuff injections in a ring pattern around the tear itself rather than dispersing to unrelated sites. you can hit 2-week spacing gaps within a 3-inch radius if you’re systematic and actually mark your sites. the lumps are a real problem, but dragging BPC far from the lesion you’re trying to heal seems like the worse trade.
Spacing sites wider definitely matters, but you changed three variables at once - dilution, massage, spacing - so it’s tough to know which actually fixed the lumps. I’d lean toward spacing being the driver, not the BAC volume. Four-site rotation with 4-5 day gaps works fine for my 250mcg split if depth is solid. Two-plus weeks might be overcorrecting.
The “BPC works in the tissue” line is the bit I’d underline twice, because it’s the part most people gloss over when they’re troubleshooting injection lumps. The local pharmacodynamics matter here in a way they don’t with, say, a TRT ester sitting in an oil depot waiting to partition out. With a peptide in BAC water you’ve got a small bolus of an osmotically active solution sitting in a fairly fixed tissue plane, and if the surrounding fascia hasn’t had time to clear the previous shot’s inflammatory residue, the next one lands on irritated ground. Your rotation observation is, I think, the actual mechanism, not a workaround. A few additions from what I’ve read in the subq insulin literature (which is the closest well-studied analogue, since BPC PK in humans is mostly extrapolation): site spacing of at least 1cm from the previous injection, and ideally a 2-3 week return window for any given subregion, is roughly what reduces lipohypertrophy in long-term insulin users. The mechanism isn’t identical but the tissue-handling principle transfers reasonably well. The 2ml dilution helping is consistent with that too, lower concentration per unit volume means less local osmotic and pH disturbance, which is almost certainly more relevant than the total mcg dose for site reactions. The post-injection massage I’d be slightly more cautious about, only because for a peptide that is supposed to act locally on the tissue it’s deposited in, you may be trading off some of the local depot effect for faster systemic absorption. Probably fine for a knee injection where you’re targeting that joint anyway, possibly less ideal if you’re shooting in the quad and trying to address something elsewhere. Worth noting if you ever try sites further from the target tissue. Glad the knee’s still responding. The fact you tracked the difference between cycles is the actual valuable part of this post, honestly.
The dilution story is the one I’d push on. Going from 1.5 to 2ml at the same 250mcg dose changes injection volume but not the total mass of peptide deposited, and the local tissue response to BPC-157 is a function of how much peptide ends up in a given depot, not how much saline carries it in. If wider rotation alone resolved the lumps in 5 days, that’s probably doing most of the work, and the volume change is a confound. The other thing worth flagging: “nothing red or hot, just pea-sized bumps” on a peptide that’s literally pro-angiogenic and pro-fibroblast in the tissue is not super surprising, and a degraded or contaminated vial doesn’t always announce itself either. Worth eyeballing the vial against a fresh one if the pattern repeats.
you changed three variables at once (dilution, massage, rotation), so idk which one actually fixed the lumps. 1.5ml to 2ml doesn’t obviously explain inflammation, and massage is probably doing way more work than you’re crediting. also, other subq compounds don’t cause lumps from tight rotation, so why would bpc specifically? is this more of a batch reaction thing that happened to line up with your site spacing changes?
‘BPC works in the tissue’ - so wider spacing definitely makes sense. Thing is, you changed three things at once (dilution, massage, rotation), so it’s hard knowing which one actually fixed the lumps. Spacing probably did most of the lifting. Next cycle, isolate one variable and you’ll have real data on what moved it.